Rectus femoris ultrasonography as an adjunctive tool to evaluate residual muscle impairment in patients with controlled Cushing’s syndrome and acromegaly

Muscle impairment, characterized by reduced muscle quality and functional performance, may persist in patients with Cushing's syndrome (CS) in remission and acromegaly (ACRO) after long-term biochemical control. This study evaluated whether rectus femoris ultrasonography (US), using standardized thickness and volume measurements and semi-quantitative Heckmatt echogenicity grading, identifies residual muscle quality abnormalities in these patients and whether US findings relate to magnetic resonance imaging (MRI)-derived fat fraction (FF), functional performance, and patient-reported outcomes. We studied 36 women with CS in remission, 36 patients with long-term controlled ACRO, and 64 unique healthy controls used for disease-specific matched comparisons. Rectus femoris and vastus intermedius US assessed muscle size and echogenicity at mid-thigh and distal-third sites. MRI FF was measured using a 2-point Dixon sequence. Physical performance was assessed by gait speed, timed up-and-go, 30-second chair-stand, and handgrip strength tests. Quality of life (QoL) was assessed using CushingQoL, AcroQoL, and the 36-Item Short Form Health Survey (SF-36). Rectus femoris echogenicity was higher in both patient groups than in matched controls despite similar US muscle size. Higher echogenicity correlated with MRI-derived thigh FF and with selected measures of poorer physical performance. Associations with QoL were exploratory and were strongest for physical functioning-related domains, although broader disease-related and psychosocial contributors cannot be excluded. These findings support muscle US as a feasible adjunct to biochemical follow-up and MRI for identifying residual myopathy in controlled pituitary disease. Longitudinal and multicenter studies using standardized quantitative US protocols are needed to define reproducibility and clinical thresholds.

Authors

Institutions

Publication Details

Journal
Endocrine Journal
Published
2026-11-19
DOI
https://doi.org/10.1507/endocrj.ej26-0221
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rectus femoris ultrasonography as an adjunctive tool to evaluate residual muscle impairment in patients with controlled Cushing’s syndrome and acromegaly

Elena Valassi, Susan M. Webb, Luciana Martel‐Duguech, Helena Bascuñana
1 links
Endocrine Journal
Pituitary Gland Disorders and Treatments
article

Rectus femoris ultrasonography as an adjunctive tool to evaluate residual muscle impairment in patients with controlled Cushing’s syndrome and acromegaly

Elena Valassi, Susan M. Webb, Luciana Martel‐Duguech, Helena Bascuñana
article en

Abstract

Muscle impairment, characterized by reduced muscle quality and functional performance, may persist in patients with Cushing's syndrome (CS) in remission and acromegaly (ACRO) after long-term biochemical control. This study evaluated whether rectus femoris ultrasonography (US), using standardized thickness and volume measurements and semi-quantitative Heckmatt echogenicity grading, identifies residual muscle quality abnormalities in these patients and whether US findings relate to magnetic resonance imaging (MRI)-derived fat fraction (FF), functional performance, and patient-reported outcomes. We studied 36 women with CS in remission, 36 patients with long-term controlled ACRO, and 64 unique healthy controls used for disease-specific matched comparisons. Rectus femoris and vastus intermedius US assessed muscle size and echogenicity at mid-thigh and distal-third sites. MRI FF was measured using a 2-point Dixon sequence. Physical performance was assessed by gait speed, timed up-and-go, 30-second chair-stand, and handgrip strength tests. Quality of life (QoL) was assessed using CushingQoL, AcroQoL, and the 36-Item Short Form Health Survey (SF-36). Rectus femoris echogenicity was higher in both patient groups than in matched controls despite similar US muscle size. Higher echogenicity correlated with MRI-derived thigh FF and with selected measures of poorer physical performance. Associations with QoL were exploratory and were strongest for physical functioning-related domains, although broader disease-related and psychosocial contributors cannot be excluded. These findings support muscle US as a feasible adjunct to biochemical follow-up and MRI for identifying residual myopathy in controlled pituitary disease. Longitudinal and multicenter studies using standardized quantitative US protocols are needed to define reproducibility and clinical thresholds.

Endocrine Journal
Universitat Autònoma de Barcelona (ES), Hospital de Sant Pau (ES), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), Hospital Universitari Germans Trias i Pujol (ES), Institut de Recerca Sant Pau (ES)
Instituto de Salud Carlos III
Good health and well-being
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon